Overview

Privately held central nervous system (CNS)-focused therapeutics company founded in March 2013 by biologist and pharmacologist James P. Pearson PhD (JPP) and medicinal chemist/ process chemist Eduardo J. Martinez PhD (EJM) based in Cambridge MA, USA. Sea Pharma invents, discovers, advances, does research & development (R&D) and plans to commercialize Sea's own novel proprietary synthetic small molecules as innovative treatments for Tinnitus, Epilepsy and other high medical need therapeutic neurology indications including genetic disorders of the CNS. Sea works with a network of Key Opinion Leaders and top Contract work organizations and some Academic labs in neuroscience (neurobiology, in vivo neurology, neuro-pathophysiology and whole-cell patch clamp electrophysiology), in vivo and in vitro pharmacology, toxicology, chemistry, translational medicine, clinical operations and clinical research, Sea Pharmaceuticals LLC is a State of Iowa Limited Liability Company. Sea has 8 board members (i) JPP, Sea president, CEO and chief scientist (ii) Ben Cravatt PhD neurochemist /biologist Professor TRSI (Scripps), member National Academy of Sciences; ActivX ( Kyorin), Abide (Lundbeck), Vividion (Bayer); (iii) Eric R Olson PhD biologist and pharmacologist CSO Syros Inc Cambridge MA, and Trustee Cystic Fibrosis Foundation (CFF); drug maker 4 life-saving CF drugs Kalydeco_TM, Orkambi_TM, Symdeco_TM, Trikafta_TM, frmr Aurora Biosciences INC / Vertex, Warner Lambert (WL) Parke-Davis (PD), Upjohn (U); (iv) Mark G. Currie PhD (frmr President and CSO Cyclerion Inc and current board member Ironwood IRWD; frmr Sepracor, Monsanto); drug maker Celebrex_TM, Bextra_TM, Lunesta_TM, Xopenex_TM, and Linzess_TM ;(v) Michael J Higgins MBA (frmr Ironwood Pharma, Genzyme, Procept); (vi) Shaker Sadasivam PhD frmr CEO Sun Edison Semi Conductor (SEMI sold in 2016), Monsanto; (vii) Nabil Elkouh PhD, Erigo LLC and expert metals and battery engineer; (viii) W. Kendall Brown JD physicist and lawyer.